92 research outputs found
Amiodarone pulmonary toxicity - Dose and duration of treatment are not the only determinants of toxicity
Amiodarone pulmonary toxicity - Dose and duration of treatment are not the only determinants of toxicity
Cardiologists and cardiac surgeons:Towards an integrated approach facing the forthcoming scenario of coronary artery disease
Defining the problem of intractable angina:implications for therapeutic approaches in the relief of ischaemic cardiac pain
Defining the problem of intractable angina:implications for therapeutic approaches in the relief of ischaemic cardiac pain
An unusual case of cardiac tamponade following electrical cardioversion
The clinical presentation of cardiac tamponade may uncover underlying pericardial disease. We describe a patient who was being treated for lone atrial fibrillation, In this case, direct current cardioversion for recurrence of atrial fibrillation was complicated by a life-threatening hemopericardium. A history of asbestos exposure was subsequently related to the subclinical pericarditis
Current views on neurostimulation in the treatment of cardiac ischemic syndromes
Most clinicians are still unacquainted with the beneficial effects of neurostimulation as an additional therapeutic strategy for severe angina pectoris. Patients with therapeutically refractory angina pectoris suffer from chest discomfort during minimal exercise, despite maximal tolerated antianginal drug therapy (at least 2 out of a beta-blocker, calcium-antagonist or long-acting nitrate). In these patients, revascularization procedures, such as a percutaneous transluminal coronary angioplasty or coronary artery bypass surgery, are often technically impossible because of diffuse coronary artery disease or should be withheld as a consequence of absolute contraindications such as severe left ventricular dysfunction. All patients have inoperable multivessel disease, experienced one or more myocardial infarctions, and were treated by earlier invasive interventions. This group of patients are severely physically and psychologically disabled by their intractable angina pectoris. Available published data and the neurostimulation experience of the authors are reviewed in relation to the treatment of cardiac ischemic syndromes. We conclude that neurostimulation is an effective therapeutic adjuvant for patients with severe angina pectoris unresponsive to standard treatment. This treatment modality appears to be safe, and a promising tool for other ischemic cardiac syndromes
Cardiologists and cardiac surgeons:Towards an integrated approach facing the forthcoming scenario of coronary artery disease
- …